Alexia Spring

Dr. Alexia Spring

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Lazio, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
Marta ChiaravalliMarta Chiaravalli
Marta Chiaravalli
ASAlexia Spring
Alexia Spring
AAAntonio Agostini
Antonio Agostini
GPGeny Piro
Geny Piro
CCCarmine Carbone
Carmine Carbone
Giampaolo TortoraGiampaolo Tortora
Giampaolo Tortora
Immunogenic cell death (ICD) is a regulated form of cell death that induces the activation of both innate and adaptive immune responses through the release of damage-associated molecular patterns (DAMPs) and their subsequent recognition by pattern-recognition receptors (PRRs), generating specific CD8+ T lymphocytes. Thus, ICD inducers (such as certain chemotherapeutic agents, targeted therapies, radiation, and oncolytic viruses) could become a potential cancer treatment by providing antitumour immunity and cancer vaccination. Moreover, their combination with immunotherapy, especially with immune checkpoint inhibitors, could overcome the immunosuppressive tumour microenvironment that characterises certain cancers, including gastrointestinal cancers. This review will provide insights into the role of ICD induction in colorectal, gastric, pancreatic, and hepatocellular carcinomas. Specifically, we will discuss the main mechanisms involved in ICD, their potential application in gastrointestinal cancer treatment, and the latest clinical trial updates.